TL;DR
This paper reveals that RNA transcripts, produced locally at specific gene locations, are crucial for the formation and function of oncogenic protein condensates (ENL mutants) that drive cancer. By binding to ENL, these RNA molecules promote the assembly of these condensates, leading to amplified oncogenic gene expression and ultimately, tumorigenesis.
What Problem Does This Paper Address?
Cancer cells often hijack normal cellular processes to promote uncontrolled growth. One such process involves the formation of protein "condensates" – dense, localized assemblies of proteins that can regulate gene expression. Aberrant condensates, particularly those involving the protein ENL, are implicated in driving certain leukemias and Wilms tumors. While the intrinsic properties of ENL mutations are known to promote condensate formation, how the surrounding cellular environment influences these pathogenic condensates has remained unclear. This paper investigates the role of RNA, a known component of many cellular condensates, in modulating the formation and function of these cancer-driving ENL condensates.
Methods
The researchers employed a multi-pronged approach:
- In vitro binding assays (EMSA): To determine if ENL directly binds RNA and DNA.
- Computational modeling (AlphaFold3): To predict potential RNA-binding regions within ENL.
- Cellular RNA-binding assays (CLAP-seq): To identify RNA molecules that bind to ENL within living cells.
- In vitro droplet assays: To observe and quantify condensate formation by purified ENL protein in the presence or absence of RNA.
- Immunofluorescence microscopy: To visualize ENL condensates in cells and their colocalization with target genes.
- Chromatin Immunoprecipitation followed by quantitative PCR (ChIP-qPCR) and sequencing (ChIP-seq): To assess ENL's binding to chromatin at specific genomic loci and genome-wide.
- RNA sequencing (RNA-seq): To measure changes in gene expression.
- Chemically induced condensate displacement and re-nucleation: A novel system to study how condensates reform after being disrupted.
- Mouse models: To assess the role of ENL-RNA interactions in leukemogenesis.
Datasets
- RNA sequences: ~100 diverse RNA sequences were used for AlphaFold3 modeling.
- CLAP-seq data: Generated from HEK293 cells expressing wildtype ENL (ENL-WT) and oncogenic ENL-T1 mutant.
- ChIP-seq data: Generated from HEK293 and MDA-MB-231 cells expressing FLAG-ENL variants.
- RNA-seq data: Generated from HEK293 and MDA-MB-231 cells expressing ENL variants.
- Publicly available datasets: Mentioned for GSEA analysis (e.g., LSK_T1 top-bound genes, HUANG AML LSC47).
Key Insights and Ideas
- RNA as a crucial cofactor: The study reveals that RNA isn't just a passive bystander but an active player in promoting ENL-driven cancer. It acts as a critical cofactor for ENL's oncogenic activity.
- Specific RNA binding site: ENL's YEATS domain, known for binding acetylated histones, also harbors a conserved basic patch that directly interacts with RNA. This dual binding capability is key.
- RNA-dependent condensate nucleation: RNA binding is not just about stabilizing condensates; it's essential for their initial formation (nucleation) at specific genomic locations.
- Targeted recruitment: RNA binding preferentially enhances ENL's presence at "condensate-permissive" genomic sites, suggesting a mechanism for targeting these pathogenic condensates to specific oncogenic loci.
- RNA's role in transcriptional bursting: The presence of ENL-RNA condensates leads to increased "transcriptional bursting" – periods of intense gene activity – which is critical for driving cancer.
Key Results
- ENL binds RNA: Both in vitro and in cells, ENL was shown to bind RNA, primarily through a basic patch in its YEATS domain.
- RNA enhances ENL condensate formation: In vitro droplet assays showed that RNA significantly boosted the formation of ENL condensates, especially for oncogenic ENL mutants.
- RNA binding is critical for ENL condensate formation in cells: Mutating the RNA-binding site in ENL (T1-3A variant) partially reduced condensate formation in various cell lines.
- ENL-RNA interactions promote condensate localization to target genes: In HEK293 cells, ENL condensates colocalized with HOXA and CBX3 loci, and this colocalization was reduced in the RNA-binding deficient mutant.
- RNA binding enhances oncogenic gene activation: Disrupting ENL-RNA interactions led to reduced transcriptional bursting and activation of key oncogenic target genes.
- RNA binding is essential for leukemogenesis: In mouse models, impairing ENL-RNA interactions significantly suppressed ENL mutant-driven leukemia development.
Limitations and Future Work
- Defining condensate-permissive loci: The study identifies that only a "small, cell type-specific subset" of target sites is permissive to condensate formation, but the molecular features defining these loci remain to be elucidated.
- Broader implications of RNA-dependent condensate regulation: The authors suggest that RNA-dependent condensate regulation might be a broader strategy used by cancer cells to achieve persistent pathogenic gene activation, a hypothesis that warrants further investigation.
- Specific RNA species: While intron-containing RNA transcripts proximal to target genes are suggested as key RNA species, further work could pinpoint the exact RNA molecules involved.
Summary updated